Using AI to advance digital transformation in healthcare

Written by:

Cindy Hoots

Chief Digital Officer & CIO

Jim Weatherall

VP, Data Science & AI, AstraZeneca R&D

Anna Asberg

VP R&D IT, AstraZeneca

At AstraZeneca, we are using the power of artificial intelligence (AI) and data science to accelerate drug discovery and development, improve patient experiences and move us from doing digital to being digital.

In this AI Audio Special, we explore how user experience is at the heart of AI and discuss how we are using AI to help us analyse and interpret huge quantities of data at all stages of drug discovery and development, with a number of aims in view:

  • Gaining a better understanding of the diseases we want to treat 
  • Identifying new targets for novel medicines 
  • Speeding up the way we design, develop and make new drugs 
  • Designing and recruiting for better clinical trials 

The programme also covers how high-quality data is the foundation for using AI across AstraZeneca (data that are findable, accessible, interoperable and reusable); discusses collaborations we have with industry and academia; and explores our approach to data and AI ethics.

Ultimately, we hope that applying AI and machine learning across R&D will increase the probability of success and reduce timelines in our drug discovery and development process.  

Join us as we continue to explore ways where AI can make a meaningful impact to our science, medicines, and society.